Latest Breaking News On - Bmsvenkat sethuraman - Page 1 : comparemela.com

In 2022, Bristol Myers Squibb (BMS) announced plans to work with AI developer Owkin to design and optimize cardiovascular drug trials. The.

Ed misetaVenkat sethuramanBristol myers squibbBmsvenkat sethuramanData sciencesChief editorGlobal biometricsArtificial intelligenceDigital protocol solution